Results 291 to 300 of about 307,775 (306)

Significance of neurochemical parameters in the preclinical evaluation of neuroleptic drugs

Pharmacology & Therapeutics, 1979
F, Cattabeni, C L, Galli, A, Groppetti, G, Racagni   +3 more
openaire   +2 more sources

Preclinical development of molecular-targeted agents for cancer

Nature Reviews Clinical Oncology, 2010
Alberto Ocana, Atanasio Pandiella, Lillian L Siu   +2 more
exaly  

Advances in organ-on-a-chip engineering

Nature Reviews Materials, 2018
Boyang Zhang, Anastasia Korolj, Milica Radisic   +2 more
exaly  

Yawning behavior for preclinical drug evaluation.

Methods and findings in experimental and clinical pharmacology, 1996
openaire   +1 more source

The adult human brain in preclinical drug development

Nature Reviews Drug Discovery, 2008
Mike Dragunow
exaly  

[The problem of preclinical evaluation of psychotropic drugs].

Acta neurologica, 1970
M, Tansella, G, Dello Russo
openaire   +1 more source

Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes

Nature Reviews Drug Discovery, 2011
Thomas Force, Kyle L Kolaja
exaly  

[Preclinical possibilities of evaluating nonrenal elimination of drugs].

Ceskoslovenska fysiologie, 1990
M, Bohdanecká, O, Schück, V, Reitschlägerová   +2 more
openaire   +1 more source

[Preclinical evaluation of new drugs].

Munchener medizinische Wochenschrift (1950), 1973
openaire   +2 more sources

[Preclinical evaluation of drug induced QT prolongation].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003
openaire   +1 more source